European Medicines Agency guideline on bioanalytical method validation: what more is there to say?

References

• 1  EBF and EUFEPS Workshop on: EMEA Draft Guideline on Validation of Bioanalytical Methods. Brussels, Belgium, 15–16 April 2010.
  Google Scholar
• 2  Amsterdam PV. How to implement the EMA Guideline on bioanalytical method validation. Presented at: EBF 4th Open Symposium. Barcelona, Spain, 16–18 November 2011.
  Google Scholar
• 3  Viswanathan CT, Bansal S, Booth B et al. Quantitative bioanalytical methods validation: best practices for chromatographic and ligand binding assays. AAPS J.9(1),E30–E42 (2007).
  Google Scholar
• 4  Hughes NC, Wong EYK, Fan J, Bajaj N. Determination of carryover and contamination for mass spectrometry-based chromatographic assays. AAPS J.9(3),E353–E360 (2007).
  Medline CASGoogle Scholar
• 5  Hughes NC, Bajaj N, Fan J, Wong EYK. Assessing the matrix effects of hemolyzed samples in bioanalysis. Bioanalysis1(6),1057–1066 (2009).
  CASGoogle Scholar
• 6  Sangster T. EMA – have our prayers been answered? Presented at: EBF 4th Open Symposium. Barcelona, Spain, 16–18 November 2011.
  Google Scholar
• 7  Freisleben A, Brudny-Klöppel M, Mulder H, de Vries R, de Zwart M, Timmerman P. Blood stability testing: European Bioanalysis Forum view on current challenges for regulated bioanalysis. Bioanalysis3(12),1333–1336 (2011).
  CASGoogle Scholar
• 101  European Medicines Agency. Draft guideline on validation of bioanalytical methods. EMEA/CHMP/EWP/192217/2009 (2009). www.ema.europa.eu/pdfs/human/ewp/19221709en.pdf
  Google Scholar
• 102  European Medicines Agency. Guideline on validation of bioanalytical methods. EMEA/CHMP/EWP/192217/2009 (2009). www.ema.europa.eu
  Google Scholar
• 103  US FDA. Guidance for Industry: bioanalytical method validation. US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville, MD, USA (2001). www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070107.pdf
  Google Scholar
• 104  European Medicines Agency. Guideline on the evaluation of control samples in nonclinical safety studies: checking for contamination with the test substance. CPMP/SWP/1094/04 (2005). www.ema.europa.eu
  Google Scholar